Centenarian stroke treated with tissue-type plasminogen activator

被引:14
|
作者
Gorman, MJ
Tanne, D
Lewandowski, CA
机构
[1] Wayne State Univ, Sch Med, Dept Neurol, Stroke Program, Detroit, MI 48201 USA
[2] Henry Ford Hlth Sci Ctr, Dept Emergency Med, Detroit, MI USA
[3] Chaim Sheba Med Ctr, Dept Neurol, Stroke Unit, IL-52621 Tel Hashomer, Israel
关键词
stroke; thrombolysis; elderly; tissue-type plasminogen activator;
D O I
10.1159/000057857
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Elderly patients with acute ischemic stroke often do worse than younger counterparts independent of thrombolytic therapy. Further, tissue-type plasminogen activator, (t-PA) is frequently withheld from the very old. This may be the result of comorbid conditions prohibiting its use or possibly the fear of causing more harm than good. We present a case of a 100-year-old woman who was treated with t-PA for acute ischemic stroke with rapid resolution of symptoms. Case Description: A 100 year-old woman presented to the emergency department with slurred speech, right hemiparesis and right hemisensory loss. Computed tomography revealed neither hemorrhage nor early ischemic changes. Intravenous t-PA was administered at 0.9 mg/kg 3 min prior to the 3-hour limit. She improved rapidly (NIHSS from 12 on admission to 4 at 1 month) and was discharged to the care of her family after 4 hospital days. Conclusion: Intravenous thrombolysis may be beneficial in the very elderly and should be considered in any eligible elderly patients with acute ischemic stroke, with a risk/benefit analysis individualized to each case. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:285 / 287
页数:3
相关论文
共 50 条
  • [31] Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience
    Katzan, IL
    Furlan, AJ
    Lloyd, LE
    Frank, JI
    Harper, DL
    Hinchey, JA
    Hammel, JP
    Qu, A
    Sila, CA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09): : 1151 - 1158
  • [32] Asymmetric Dimethylarginine in Response to Recombinant Tissue-Type Plasminogen Activator and Erythropoietin in Acute Stroke
    Worthmann, Hans
    Martens-Lobenhoffer, Jens
    Joumaah, Majed
    Li, Na
    Lichtinghagen, Ralf
    Hecker, Hartmut
    Kielstein, Jan T.
    Ehrenreich, Hannelore
    Bode-Boeger, Stefanie M.
    Weissenborn, Karin
    [J]. STROKE, 2013, 44 (08) : 2128 - 2133
  • [33] Combination therapy stroke trial: Recombinant tissue-type plasminogen activator with/without lubeluzole
    Grotta, J
    [J]. CEREBROVASCULAR DISEASES, 2001, 12 (03) : 258 - 263
  • [34] Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke
    Grond, M
    Rudolf, J
    Schmülling, S
    Stenzel, C
    Neveling, M
    Heiss, WD
    [J]. ARCHIVES OF NEUROLOGY, 1998, 55 (04) : 466 - 469
  • [35] Quality improvement and tissue-type plasminogen activator for acute ischemic stroke - A Cleveland update
    Katzan, IL
    Hammer, MD
    Furlan, AJ
    Hixson, ED
    Nadzam, DM
    [J]. STROKE, 2003, 34 (03) : 799 - 800
  • [36] Stroke Treatment With Intravenous Tissue-Type Plasminogen Activator More Proof That Time Is Brain
    Alberts, Mark J.
    [J]. CIRCULATION, 2017, 135 (02) : 140 - 142
  • [37] Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke
    Wang, Chunyang
    Huang, Rui
    Li, Chao
    Lu, Mei
    Emanuele, Martin
    Zhang, Zheng Gang
    Chopp, Michael
    Zhang, Li
    [J]. STROKE, 2019, 50 (12) : 3600 - 3608
  • [38] RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR THERAPY IN ACUTE THROMBOEMBOLIC STROKE
    PAPADOPOULOS, SM
    CHANDLER, WF
    SALAMAT, MS
    TOPOL, EJ
    SACKELLARES, JC
    [J]. JOURNAL OF NEUROSURGERY, 1987, 67 (03) : 394 - 398
  • [39] Genetic Variation at the Human Tissue-Type Plasminogen Activator (tPA) Locus and the Risk of Stroke
    Munshi, A.
    Jyothy, A.
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2010, 51 (07) : 724 - 724
  • [40] Influence of Obesity on Effectiveness of Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke
    Schlick, Konrad
    Raman, Rema
    Hemmen, Thomas
    Meyer, Brett
    Meyer, Dawn
    Ernstrom, Karin
    Ovbiagele, Bruce
    [J]. NEUROLOGY, 2012, 78